Covered recipient · General Payments record
JOHN TODD LOUIS
Allopathic & Osteopathic Physicians Surgery Plastic and Reconstructive Surgery
General Payments · PY2018–2024
$1,551.95
- Reported across 52 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $303.41 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $143.40 | 8 |
| Incyte Corporation | $59.15 | 3 |
| Lilly USA, LLC | $30.93 | 2 |
| Janssen Biotech, Inc. | $28.46 | 1 |
| ANI Pharmaceuticals, Inc. | $22.03 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $19.44 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ANI Pharmaceuticals, Inc. | $22.03 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091172594 | CMS |
| Incyte Corporation | $17.04 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141175027 | CMS |
| Incyte Corporation | $21.07 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141176198 | CMS |
| Incyte Corporation | $21.04 | 10/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141176270 | CMS |
| Janssen Biotech, Inc. | $28.46 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078611805 | CMS |
| Lilly USA, LLC | $15.11 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135059712 | CMS |
| Lilly USA, LLC | $15.82 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135072853 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $19.44 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152162303 | CMS |
| UCB, Inc. | $17.15 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143287811 | CMS |
| UCB, Inc. | $17.54 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143287815 | CMS |
| UCB, Inc. | $19.47 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143287820 | CMS |
| UCB, Inc. | $17.92 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143287824 | CMS |
| UCB, Inc. | $30.35 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143287828 | CMS |
| UCB, Inc. | $15.15 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143287833 | CMS |
| UCB, Inc. | $3.05 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143287837 | CMS |
| UCB, Inc. | $22.77 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143287841 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.